Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 7, 2003 - Issue 3
Submit an article Journal homepage
93
Views
51
CrossRef citations to date
0
Altmetric
Review

Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases

Alessandro Lecci Pharmacology Department of Menarini Ricerche, via Rismondo 12/A, 50131 Florence, Italy. [email protected]
&
Carlo Alberto Maggi Pharmacology Department of Menarini Ricerche, via Rismondo 12/A, 50131 Florence, Italy. [email protected]
Pages 343-362 | Published online: 02 Mar 2005

Bibliography

  • NEUMANN S, DOUBELL TP, LESLIE T, WOOLF CJ: Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature (1996) 384:360–364.
  • ••First evidence that TKs can be synthesised and released from large sensory neurons possessing A fibres.
  • HUNTER DD, MYERS AC, UNDEM BJ: Nerve growth factor-induced phenotypic switch in guinea-pig airway sensory neurons. Am. I Respir. Grit. Care Med. (2000) 161:1985–1990.
  • MYERS AC, KAJEKAR R, UNDEM BJ: Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea-pig airways. Am. I Physiol. Lung Mol. Physiol. (2002) 282:L775–L781.
  • CARR MJ, HUNTER DD, JACOBY DB, UNDEM BJ: Expression of tachykinins in non-nociceptive vagal afferent neurons during respiratory viral infection in guinea-pigs. Am. I Respir Grit. Care Med. (2002) 165:1071–1075.
  • LECCI A, VALENTI C, MAGGI CA: Tachykinin receptor antagonists in irritable bowel syndrome. Curr. Opin. Invest. Drugs (2002) 3:589–601.
  • PEREZ FONTAN JJ, CORTRIGHT DN, KRAUSE JE et al.: Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat. Am. I Physiol Lung. Cell Mol. Physiol (2000) 278:L344–L355.
  • FREIDIN M, KESSLER JA: Cytokine regulation of substance P expression in sympathetic neurons. Proc. Nati Acad. Sci. USA (1991) 88:3200–3203.
  • ZIGMOND RE, SUN Y: Regulation of neuropeptide expression in sympathetic neurons. Paracrine and retrograde influences. Ann. NY Acad. ScL (1997) 814:181–197.
  • MURPHY SM, MATTHEW SE, RODGERS HF, LITURI DT, GIBBINS IL: Synaptic organization of neuropeptide-containing preganglionic boutons in lumbar sympathetic ganglia of guinea-pigs. .I. Comp. Neurol. (1998) 398:551–567.
  • SASEK CA, SEYBOLD VS, ELDE RP: The immunohistochemical localization of nine peptides in the sacral parasympathetic nucleus and the dorsal gray commissure in rat spinal cord. Neuroscience (1984) 12:855–873.
  • MAGGI CA: The effects of tachykinins on inflammatory and immune cells. Regul. Pep] (1997) 70:75–90.
  • JOOS GE DE SWERT KO,PAUWELS RA: Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur. Pharmacol. (2001) 429:239–250.
  • DE GIORGIO R, TAZZARI PL, STANGHELLINI V, CORINALDESI R: Detection of substance P immunoreactivity in human peripheral leukocytes. Neuroimmunol. (1998) 82:175–181.
  • ZHANG Y, LU L, FURLONGER C, WU GE, PAIGE CJ: Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol (2000) 1:392–397.
  • ••Discovery of a novel TK gene and peptide expressed in non-neuronal cells in the periphery.
  • SIMON C, PORTALIER P,CHAMOIN MC, TERNAUX JP: Substance P like-immunoreactivity release from enterochromaffin cells of rat caecummucosa. Inhibition by serotonin and calcium-free medium. Neurochem. (1992) 20:529–536.
  • CHU HV, KRAFT M, KRAUSE JE, REX MD, MARTIN RJ: Substance P and its receptor neurokinin 1 expression in asthmatic airways. I Allergy Clin. Immunol. (2000) 106:713–722.
  • PAGE NM, WOODS RJ, LOWRY PJ: A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul. Pep] (2001) 98:97–104.
  • PINTO FM, CINTADO CG,DEVILLIER P, CANDENAS ML: Expression of preprotachykinin-B, the gene that encodes neurokinin B, in rat uterus. Eur. Pharmacol. (2001) 425:R1–R2.
  • BAE SJ, MATSUNAGA Y, TAKENAKA M et al.: Substance P-induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblast. Lit. Arch. Allergy Immunol. (2002) 127:316–321.
  • IYAGOSTINO B, ADVENIER C, FALCIANI M et al.: Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis induction. BE J. Pharmacol. (2001) 134:1447–1454.
  • MAGHNI K, MICHOUD MC, ALLES M et al.: Airway smooth muscle cells express functional neurokinin-1 receptors and the nerve-derived preprotachykinin-A gene. Am. I Respir. Cell Mol. Biol. (2003) 28:103–110.
  • ••Evidence that smooth muscle cells can become a novel source of TKs.
  • FONG TM, ANDERSON SA, YU H, HUANG RR, STRADER CD: Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. (1992) 41:24–30.
  • KAGE R, LEEMAN SE, BOYD ND: Biochemical characterization of two different forms of the substance P receptor in rat submaxillary gland. .1 Neurochem. (1993) 60:347–351.
  • CANDENAS ML, CINTADO CG, PENNEFATHER JN et al: Identification of a tachykinin NK2 receptor splice variant and its expression in human and rat tissues. Life ScL (2002) 72:269–277.
  • PAGE NM, BELL NJ: The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal. Eur. Pharmacol (2002) 437:27–30.
  • DERY 0, DEFEA KA, BUNNETT NW: Protein kinase C-mediated desensitization of the neurokinin-1 receptor. Am. .1 Physiol. Physiol. (2001) 280:C1097–C1106.
  • TRAFTON JA, ABBADIE C,BASBAUM Al: Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat. Neuracci. (2001) 21:3656–3664.
  • •Evidence indicating that NKA is a physiological agonist for NK-1 receptors and that the mode of activation of these receptors by NKA differs from that induced by SP.
  • BELLUCCI F, CARINI F, CATALANI C et al: Pharmacological profile of the novel mammalian tachykinin hemokinin 1. Br. Pharmacol (2002) 135:266–274.
  • RUPNIAK NMJ, KRAMER MS: Discovery of the anti-depressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol. ScL (1999) 20:485–490.
  • ••This review anticipates that TK receptorantagonists could become drugs.
  • DUFFY RA, VARTY GB, MORGAN CA, LACHOWICZ JE: Correlation of neurokinin (NK)-1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists. J. Pharmacol Exp. Ther. (2002) 301:536–542.
  • FONG TM, YU H, STRADER CD: Molecular basis for the species selectivity of neurokinin-1 receptor antagonists CP96345 and RP67580../. Biol. Chem. (1992) 267:25668–25671.
  • JENSEN CJ, GERARD NP, SCHWARTZ TW, GETHER U: The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Mol Pharmacol (1994) 45:294–299.
  • ROGERS DF: Tachykinin receptor antagonists for asthma and COPD. Expert Opin. Ther. Patents (2001) 11:1097–1121.
  • MAZZONE SB, GERAGHTY DP: Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br j Pharmacol. (2000) 129:1121–1131.
  • RICCIARDOLO FLM, TREVISANI M, GEPPETTI P, NADEL JA, AMADESI S, BERTRAND C: Role of nitric oxide and septide-insensitive NK1 receptors in bronchoconstriction induced by aereosolized neurokinin A in guinea-pigs. Br. J. Pharmacol (2000) 129:915–920.
  • NALINE E, MOLIMARD M, REGOLI D, EMONDS-ALT E, BELLAMY JF, ADVENIER C: Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. Am. .1 Physiol (1996) 271:L763–L767.
  • AMADESI S, MOREAU J,TOGNETTO M et al: NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi. Am. J. Respir Crit. Care Med. (2001) 163:1026–1211.
  • BARCHASZ E, NALINE E,MOLIMARD M et al: Interleukin-113-induced hyperresponsiveness to Sar9,Met(02)11-substance P in isolated human bronchi. Eur. j Pharmacol. (1999) 379:87–95.
  • VAN SCHOOR J, JOOS GECHASSON BL, BROUARD RJ,PAUWELS RA: The effect of theNK2 tachykinin receptor antagonistSR 48968 (saredutant) onneurokinin A-induced bronchoconstrictionin asthmatics. Eur. Respir: (1998) 12:17–23.
  • YU XY, UNDEM BJ, SPANNHAKE EW: Protective effect of substance P on permeability of airway epithelial cells in culture. Am. J. Physiol (1996) 271:L889–L895.
  • VERONESI B, OORTGIESEN M, CARTER JD, DEVLIN RB:Particulate matter initiates inflammatory cytokine release by activation of capsaicin and acid receptors in a human bronchial epithelial cell line. Toxicol Appl. Pharmacol (1999) 154:106–115.
  • HOOD VC, CRUWYS SC, URBAN L, KIDD BL: Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis. Reg& Pept. (2000) 96:17–21.
  • BRUNELLESCHI S, NICALI R, LAVAGNO L et al: Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers, or healthy volunteers. Neuropeptides (2000) 34:45–50.
  • BLUM AM, METWALI A, ELLIOTT DE, WEINSTOCK JV: The T-cellsubstance P receptor governs antigen-elicited IFN(y) production. Am. J. Physiol Gastrointest. Liver Physiol (2003) 284:G197–G204.
  • HOSHINO H, LOTVALL J, SKOOG B-E, LINDEN A: Neutrophil recruitment by interleukin-17 into rat airways in vivo. Am. I Respir. Grit. Care Med. (1999) 159:1423–1428.
  • KING KA, RODRIGUEZ MM, ROMAGUERA R, JIANG X, PIEDIMONTE G: Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am. I Respir tell. Mol Biol. (2001) 24:101–107.
  • JACOBY DB, YOST BL, EL WOOD T, FRYER AD: Effects of neurokinin receptor antagonists in virus-infected airways. Am. I Physiol Lung Cell. Mol Physiol (2000) 279:L59–L65.
  • NAGANO Y, TAMAOKI J,NISHIMURA K, YAMAWAKI I,NAGAI A: Adenosine A3 receptor-mediated airway microvascular leakage: role of mast cells and tachykinins. Res. Commun. Mol Pathol Pharmacol (2000) 108:96–107.
  • BALUK P, BERTRAND C, GEPPETTI P, MCDONALD DM, NADEL JA:NK1 receptor antagonist CP-99994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules. Exp. Lung Res. (1996) 22:409–418.
  • LIN YS, HO CY, TANG GJ, KOU YR: Alleviation of wood smoke-induced lung injury by tachykinin receptor antagonist and hydroxyl radical scavenger in guinea-pigs. Eur. Pharmacol (2001) 425:141–148.
  • SCHUILING M, ZUIDHOF AB, ZAAGSMA J, MEURS H: Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea-pigs. Am. I Respir. Grit. Care Med. (1999) 159:423–430.
  • HAMAMOTO J, KOHROGI H, KAWANO 0 et al: Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways in guinea-pigs. Appl. Physiol (1997) 82:738-745.356Evidence for the involvement of the axon reflex in pathological mechanisms at the visceral level.
  • KOHOROGI H, HAMAMOTO J, KAWANO 0 et al.: The role of substance P release in the lung with esophageal acid. Am. J. Med. (2001) 111(Suppl. 8A):S25–S30.
  • DAOUI S, D'AGOSTINO B,GALLELLI L, EMONDS-ALT X, ROSSI F, ADVENIER C: Tachykinins and airway microvascular leakage induced by HC1 intrao-oesophageal instillation. Eur. Respic J. (2002) 20:268–273.
  • BOICHOT E, BIYAH K, GERMAIN N, EMONDS-ALT X, LAGENTE V,AD VENTER C: Involvement of tachykinin NK1 and NK2 receptors insubstance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs. Eur. Resp. (1996) 9:1445–1450.
  • HSU TH, LAI YL, KOU YR: Acetylcholine and tachykinin receptor antagonists attenuate wood smoke-induced bronchoconstriction in guinea-pigs. Eur. Pharmacol (1998) 360:175–183.
  • COSTELLO RW, FRYER AD, BELMONTE KE, JACOBY DB: Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal muscarinic receptor function in antigen-challenged guinea-pigs. Brj Pharmacol (1998) 124:267–276.
  • WU ZX, MAIZE DF Jr,SATTERFIELD BE, FRAZER DG, FEDAN JS, DEY RD: Role of intrinsic airway neurons in ozone-induced airway hyperresponsiveness in ferret trachea. J. App.]. Physiol (2001) 91:371–378.
  • TERAMOTO S, TANAKA H, KANEKO S, ABE S: Neurokinin-1 receptor antagonist inhibits short-term sulfuric acid-induced airway hyperresponsiveness in sensitized guinea-pigs. Int. Arch. Allergy Immunol (2000) 121:53–56.
  • TRAMONTANA M, SANTICIOLI P, GIULIANI S et al.: Role of tachykinins in Sephadex-induced airway hyperreactivity and inflammation in guinea-pigs. Eur. Pharmacol (2002) 439:149–158.
  • •Evidence for a pathophysiological role of TKs released from immune cells.
  • CURRAN DR, WALSH MT, COSTELLO RW: Interaction between inflammatory cells and nerves. Curr. Opin. Pharmacol (2002) 2:243–248.
  • ICHINOSE M, MIURA M, YAMAUCHI H et al: A neurokinin-1 receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am. I Respir. Grit. Care Med. (1996) 153:936–941.
  • FAHY JV, WONG HH, GEPPETTI P et al: Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in asthmatic subjects. Am. J. Respir. Cut. Care Med. (1995) 152:879–884.
  • VAN RENSEN ELJ, HIEMSTRA PS, RABE KF, STERK PJ: Assessment of microvascular leakage via sputum induction. The role of substance P and neurokinin A in patients with asthma. Am. I Respic Grit. Care Med. (2002) 165:1275–1279.
  • MAA J, GRADY EF, KIM EH et al: NK1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation.Am. J. Physiol Castrointest. Liver Physiol (2000) 279:G726–G732.
  • HARRISON NK, DAWES KE,KWON 0J, BARNES PJ, LAURENT GJ, CHUNG KF: Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am. . 1 Physiol (1995) 268:L278–L283.
  • NOVERAL JP, GRUNSTEIN MM: Tachykinin regulation of airway smooth muscle proliferation. Am. Physiol (1995) 269:L339–L343.
  • YANG CM, HSIAO LD, CHIEN CS, LIN CC, LUO SF, WANG CC:Substance P-induced activation of P42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells. Cell. Signal. (2002) 14:913–923.
  • SHERWOOD JE, MAUSER PJ, CHAPMAN RW: Bronchoconstrictor and respiratory effects of neurokinin A in dogs. Pharmacol Exp. Ther. (1997) 283:788–793.
  • D'AGOSTINO G, ERBELDING D, KILBINGER H: Tachykinin NK2 receptors facilitate acetylcholine release from guinea-pig isolated trachea. Eur. Pharmacol (2000) 396:29–32.
  • IMASAKI T, KOBAYASHI H,HATAISHI R, HAYASHI I, TOMITA T, MAJIMA M: Nitric oxide is generated in smooth muscle layer by neurokinin A and counteracts constriction in guinea-pig airway. Nitric Oxide (2001) 5:465–474.
  • TRAMONTANA M, PATACCHINI R, GIULIANI S et al.: Characterization of the antibronchoconstrictor activity of MEN11420, a tachykinin NK2 receptor antagonist, in guinea-pigs. Eur. Pharmacol (1998) 352:279–288.
  • RIZZO CA, VALENTINE AF, EGAN RW, KREUTNER W, HEY JA: NK2 receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle. Neuropeptides (1999) 33:27–34.
  • MOUSER PJ, SKEANS S, RITACCO G, FERNANDEZ X, HOUSE A,CHAPMAN RW: Effect of tachykinins on airway function in cynomolgus monkeys. Pulm. Pharmacol Ther. (2001) 14:121–127.
  • AUBERSON S, LACROIX JS, KORDESTANI RK, LUNDBERG JM: Prejunctional control of pH 6-induced bronchoconstriction by NK1, NK2, a2-adrenoceptor and glucocorticoid receptors in guinea-pig isolated perfused lung. I Pharm. Pharmacol (1998) 50:899–905.
  • SCHUILING M, ZUIDHOF AB, MEURS H, ZAAGSMA J:Role of tachykinin NK2 receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs. BE I Pharmacol (1999) 127:1030–1038.
  • MAGHNI K, TAHA R, AFIF W, QUTAYBA H, MARTIN JG: Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell Type 2 cytokine-associated inflammation. Am. I Respic Grit. Care Med. (2000) 162:1068–1074.
  • TANPO T, NABE T, YASUI K, KAMIKI T, KOHNO S: Participation of neuropeptides in antigen-induced contraction of guinea-pig bronchi via NK2 but not NK1 receptor stimulation. Pharmacology (2000) 60:169–174.
  • WOISIN FE, MATSUMOTO T, DOUGLAS GJ, PAUL W, WHALLEY ET, PAGE CP: Effect of antagonists for NK2 and B2 receptors on antigen-induced airway responses in allergic rabbits. Pulm. Pharmacol Ther. (2000) 13:13–23.
  • WU ZX, ZHOU D, CHEN G, LEE LY: Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea-pigs. Am. I Respic Grit. Care Med. (2000) 161:73-80. 357
  • KWONG K, WU ZX, KASHON ML, KRAINAK KM, WISE PM, LEE LY: Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea-pigs. Am. j Respir. Cell. Mol. Biol. (2001) 25:299–305.
  • IIDA M, MATSUMOTO T, ISHIDA K, SAKITAMA K, NISHIKAWA K:The effects of NK5807, a novelNK2 receptor antagonist, on animal model of asthma. fpn. Pharmacol. (2001) 85:P197.
  • D'AGOSTINO B, ADVENIER C, DE PALMA R et al: The involvement of sensory neuropeptides in rabbits sensitized and challenged to Parietaria judaica. Clin. Exp. Allergy (2002) 32:472–479.
  • TOUSIGNANT C, CHAN CC, GUEVREMONT D et al: NK2 receptors mediate plasma protein extravasation in guinea-pig lower airways. Br. j Pharmacol. (1993) 108:383–386.
  • SAVOIE C, TOUSIGNANT C,RODGER IW, CHAN CC: Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs. J. Pharm. Pharmacol. (1995) 47:914–920.
  • FU L, KANEKO T, IKEDA H et al: Tachykinin via tachykinin NK2 receptor activation mediate ozone-induced increase in the permeability of tracheal mucosa in guinea-pigs. Br. j Pharmacol. (2002) 135:1331–1335.
  • D'ORTHO MP, JARREAU PH, DELACOURT C et al: Tachykinins induce gelatinase production by guinea-pig alveolar macrophages: involvement of NK2 receptors. Am. J. Physiol (1995) 269:L631–L636.
  • KRANEVELD AD, NIJKAMP FP, VAN OOSTERHOUT AJ:Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea-pigs. Am. j Respir: Grit: Care Med. (1997) 156:367–374.
  • MAPP CE, MIOTTO D, BRACCIONI F et al: The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am. j Respir. Cut. Care Med. (2000) 161:207–215.
  • LILLY CM, HALL AE, ROD GER IW, KOBZIK L, HALEY KJ, DRAZEN JM: Substance P-induced histamine release in tracheally perfused guinea-pig lungs. I Appl Physiol (1995) 78:1234–1241.
  • CROSS LG, HEANY LG, ENNIS M: Histamine release from human bronchoalveolar lavage mast cells by neurokinin A. InlIamm. Res. (1997) 46:306–309.
  • FORSYTE P, MCGARVEY LP,HEANEY LG, MACMAHON J, ENNIS M: Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin. Exp. Allergy (2000) 30:225–232.
  • CRIMI N, OLIVIERI R, POLOSA R et al: Effect of oral terfenadine on bronchoconstrictor response to inhaled neurokinin A and histamine in asthmatic subjects. Eur. Respir. J. (1993) 6:1462–1467.
  • MOORE KA, UNDEM BJ,WEINREICH D: Antigen inhalation unmasks NK2 tachykinin receptor-mediated responses in vagal afferents. Am. .1 Respir: Crit. Care Med. (2000) 161:232–236.
  • •Evidence that allergy enables NK-2 receptor agonists to depolarise vagal neurons.
  • CORDOBA-RODRIGUEZ R, GOVER TD, WEINREICH D: Are silent NK2 tachykinin receptors on primary vagal afferents really silent? Soc. Neurosci. Abs. (1999) 25:411.
  • KATSUNUMA T, MAK JC, BARNES PJ: Glucocorticoids reduce tachykininNK2 receptor expression in bovine tracheal smooth muscle. Eur. j Pharmacol. (1998) 26:99–106.
  • KATSUNUMA T, ROFFEL AF,ELZINGA CRS, ZAAGSMA J,BARNES PJ, MAK JCW:132-adrenoceptor agonist-induced upregulation of tachykinin expression and function in airway smooth muscle. Am. J. Respir: Cell. Mol. Biol. (1999) 21:409–417.
  • •A possible mechanism concurring to life-threatening asthma crisis following 13 mimetic use.
  • KATSUNUMA T, FUJITA K, MAK JC, BARNES PJ, UENO K, IIKURA Y: P-adrenergic agonists and bronchial hyperreactivity: role of 132-adrenergic and tachykinin NK2 receptors. I Allergy Clin. Immunol (2000) 106:S104–S108.
  • VAN SCHOOR J, JOOS GEPAUWELS RA: Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur. Respir: (2002) 19:997–1002.
  • JOOS GE SCHELFHOUT V, VAN DE VELDE V, MAGGI CA, PAUWELS R: The effect of the tachykinin NK2 receptor antagonist MEN11420 (nepadutant) onneurokinin A-induced bronchoconstriction in patients with asthma. Am. j Respir: Grit: Care Med. (2001) 163\(Suppl. 5):A628.
  • KRAAN J, VINK-KLOOSTER H, POSTMA DS: The NK2 receptor antagonist 5R48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthma. Clin. Exp. Allergy (2001) 31:274–278.
  • •The first pilot clinical trial of a TK receptor antagonist in asthmatics.
  • ICHINOSE M, NAKAJIMA N, TAKAHASHI T, YAMAUCHI H, INOUE H, TAKISHIMA T: Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet (1993) 340:1248–1251.
  • JOOS GE VAN SCHOOR J, KIPS JC, PAUWELS R: The effect of inhaled FK224, a tachykinin NK1 and NK2 receptor antagonist, on neurokinin A-induced bronchoconstriction. Am. . 1 Respir: Grit. Care Med. (1996) 153:1781–1784.
  • JOOS G, VINCKEN W, LOUIS R, WANG J, SHAW M, PAUWELS R:The effect of DNK333A: a dual tachykinin NK1/NK2 receptor antagonist on neurokinin A-induced bronchoconstriction in patients with asthma. Am. j Respir: Grit: Care Med. (2001) 163\(Suppl. 5):A628.
  • GIRARD V, NALINE E, VILAIN P, EMONDS-ALT X, ADVENIER C: Effects of two tachykinin antagonists, 5R48968 and SR140333, on cough induced by citric acid in the unanaesthetized guinea-pig. Eur. Respir. J. (1995) 8:1110–1114.
  • CANNING BJ, UNDEM BJ: Evidence that antidromically stimulated vagal afferents activate inhibitory neurons innervating guinea-pig trachealis. Physiol (1994) 480:613–625.
  • CANNING BJ, FISHER A, UNDEM BJ: Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea-pig trachealis. Pharmacol. Exp. Ther. (1998) 284:370–377.
  • CANNING BJ, REYNOLDS SM, ANUKU LU, KAJEKAR R, MYERS AC: Endogenous neurokinins facilitate synaptic transmission in guinea-pig airway parasympathetic ganglia. Am. j Physiol. Regul Integr. Comp. Physiol (2002) 283:R320–R330.
  • DAOUI S, NALINE E, LAGENTE V, EMONDS-ALT X, ADVENIER C:Neurokinin B and specific tachykinin NK3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig. BE J. Pharmacol (2000) 130:49–56.
  • DAOUI S, COGNON C, NALINE E, EMONDS-ALT X, ADVENIER C: Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea-pigs. Am. I Respic Crit. Care Med. (1998) 158:42–48.
  • EMONDS-ALT X, PROIETTO V, STEINBERG R et al.: Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can. J. Physiol. Pharmacol. (2002) 80:482–488.
  • HAY DWI GIARDINA GAM, GRISWOLD DE et al.: Nonpeptide tachykinin receptor antagonists. III.SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyperreactivity in guinea-pigs. ./. Pharmacol. Exp. Ther. (2002) 300:314–323.
  • PINTO FM, SAULNIER JP, FAISY C et al: SR 142801, a tachykinin NK3 receptor antagonist, prevents 132-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea. Life Sci. (2002) 72:307–320.
  • DAOUI S, AHNAOU A, NALINE E, EMONDS-ALT X, LAGENTE V, ADVENIER C: Tachykinin NK3 receptor agonists induced microvascular leakage hypersensitivity in guinea-pig airways. Eur. Pharmacol. (2001) 433:199–207.
  • NENAN S, GERMAIN N, LAGENTE V, EMONDS-ALT X, ADVENIER C, BOICHOT E: Inhibition of inflammatory cell recruitment by the tachykinin NK3-receptor antagonist, SR 142801, in a murine model of asthma. Eur. Pharmacol. (2001) 421:201–205.
  • •A mechanism through which NK-3 receptors could modulate airway hyperreactivity to motor and inflammatory stimuli.
  • PHILLIPS JE, HEY JA, CORBOZ MR: Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands. BE J. Pharmacol. (2003) 138:254–260.
  • DAOUI S, CUI YY, LAGENTE V, EMONDS-ALT X, ADVENIER C: A tachykinin NK3 receptor antagonist,SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs. Pulm. Pharmacol. Ther. (1997) 10:261–270.
  • TAKAHAMA K, FUCHIKAMI J, ISOHAMA Y, KAI H, MIYATA T: Neurokinin A but not neurokinin B and substance P, induces codeine-resistant cough in awake guinea-pigs. Regul. Pept. (1993) 46:236–237.
  • UJIIE Y, SEKIZAWA K, AIKAWA T, SASAKI H: Evidence for substance P as an endogenous substance causing cough in guinea-pigs. Am. Rev Respir. Dis. (1993) 148:1628–1632.
  • MOREAUX B, NEMMAR A, VINCKE G et al.: Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur. Pharmacol. (2000) 48:305–312.
  • XIANG A, UCHIDA Y, NOMURA A et al: Effects of airway inflammation on cough response in the guinea-pig. I Appl. Physiol. (1998) 85:1847–1854.
  • YASUMITSU R, HIRAYAMA Y, IMAI T, MIYAYASU K, HIROI J: Effects of specific tachykinin receptor antagonists on citric acid-induced cough and bronchoconstriction in unanaesthetized guinea-pigs. Eur. I Pharmacol. (1996) 300:215–219.
  • ADVENIER C, EMONDS-ALT X: Tachykinin receptor antagonists and cough. Pulm. Pharmacol. (1996) 9:329–333.
  • BOLSER DC, DEGENNARO FC, O'REILLY S, MCLEOD RL, HEY JA: Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat. Br. J. Pharmacol. (1997) 121:165–170.
  • HOLZER P, HOLZER-PETSCHE U: Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol. Ther. (1997) 73:173–217.
  • LECCI A, CARINI F, TRAMONTANA M et al: Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models. Pharmacol. Exp. Ther. (2001) 299:247–254.
  • TOULOUSE M, FIORAMONTI J, MAGGI CA, BUENO L:Role of NK2 receptors in gastric barosensitivity and in experimental ileus in rats. Neurogastroenterol. Mot. (2001) 13:45–53.
  • JONES J, BOORMAN J, CANN P et al: British society of gastroenterology guidelinesfor the management of irritable bowel syndrome. Gut (2000) 47\(Suppl. 2):S1–S19.
  • DE PONTI F, TONINI M: Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs (2001) 61:317–322.
  • LAIRD JMA, OLIVAR T, ROZA C, DE FELIPE C, HUNT SP, CERVERO F: Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykininNK1 receptor gene. Neuroscience (2000) 98:345–352.
  • OKANO S, IKEURA Y, INATOMI N: Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distension. Pharmacol. Exp. Ther. (2002) 300:925–931.
  • LEE OY, MUNAKATA J, NALIBOFF BD, CHANG L, MAYER EA: A double-blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients. Gastroenterology (2000) 118:A846.
  • •The first pilot clinical trial of a TK receptor antagonist in IBS.
  • HESKETH PJ, GRALLA RJ, WEBB RT et al: Randomized Phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. Clia Oncol. (1999) 17:338–343.
  • FURNESS JB, KUMANO K, LARSSON H, KUNZE WA, VOGALIS F: Sensitization of enteric reflexes in the rat colon in vitro. Auton. Neuracci. (2002) 97:19–25.
  • •Evidence that enteric neurons can learn.
  • TOULOUSE M, COELHO AM, FIORAMONTI J, LECCI A, MAGGI CA, BUENO L: Role of tachykininNK2 receptors in normal and altered rectal sensitivity in rats. Br. Pharmacol. (2000) 129:193–199.
  • LAIRD JMA, OLIVAR T, LOPEZ-GARCIA JA, MAGGI CA, CERVERO F: Response of rat spinal neurons to distension of inflamed colon: role of tachykinin NK2 receptors. Neuropharmacology (2001) 40:696–701.
  • BIRDER LA, KISS S, DE GROAT WC, LECCI A, MAGGI CA:Effect of nepadutant, a neurokinin 2 tachykinin receptor antagonist, on immediate-early gene expression after trinitrobenzenesulfonic acid-induced colitis in the raj. Pharmacol. Exp. Ther. (2003) 304:272–276.
  • ANTON PM, THEODOROU V, FIORAMONTI J, BUENO L:Chronic low-level administration of diquat increases the nociceptive response to gastric distension in rats: role of mast cells and tachykinin receptor activation. Path (2001) 92:219–227.
  • MCLEAN PG, PICARD C, GARCIA-VILLAR R, MORE J, FIORAMONTI J, BUENO L:Effects of nematode infection on sensitivity to intestinal distension: role of tachykinin NK2 receptors. Eur. Pharmacol (1997) 337:279–282.
  • LORDAL M, NAVALESI G, THEODORSSON E, MAGGI CA, HELLSTROM PM: A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine. BE J. Pharinacol (2001) 134:215–223.
  • •The first clinical study of a TK receptor antagonist in the GI tract.
  • WANG MJ, XIONG SH, LI ZW: Neurokinin B potentiates ATP-evoked currents in rat DRG neurons. Brain Res. (2001) 923:157–162.
  • CROCI T, EMONDS-ALT X,MANARA L: SR48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats. j Pharm. Pharmacol. (1994) 46:383–385.
  • JULIA V, SU X, BUENO L,GEBHART GF: Role of neurokinin 3 receptors on responses to colorectal distension in the rat: electrophysiological and behavioral studies. Gastroenterology (1999) 116:1124–1131.
  • EUTAMENE H, THEODOROU V, FIORAMONTI J, BUENO L:Implication of NK1 and NK2 receptors in rat colonic hypersecretion induced by interleukin 113: role of nitric oxide. Gastroenterology (1995) 109:483–489.
  • EUTAMENE H, THEODOROU V, FIORAMONTI J, BUENO L:Rectal distension-induced colonic net water secretion in rats involves tachykinins, capsaicin sensory, and vagus nerves. Gastroenterology (1997) 112:1595–1602.
  • CROCI T, LANDI M, EMONDS-ALT X, LE FUR G, MAFFRAND JP, MANARA L: Role of tachykinins in castor oil diarrhoea in rats. BE J. Pharmacol (1997) 121:375–380.
  • MORIARTY D, GOLDHILL J, SELVE N, O'DONOGHUE DP, BAIRD AW:Human colonic anti-secretory activity of the potent NK1 antagonist SR140333:assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease. BE J. Pharmacol (2001) 133:1346–1354.
  • TOUGH IR, LEWIS CA, FOZARD J, COX HM: Dual and selective antagonism of neurokinin NK1 andNK2 receptor-mediated responses in human colon mucosa. Naunyn Schrniedebergs Arch. Pharmacol (2003) 367:104–108.
  • •First evidence indicating thatTK NK-2 receptors modulate intestinal secretions in humans.
  • TURVILL JL, CONNOR P,FARTHING JG: Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum. Gastroenterology (2000) 119:1037–1044.
  • MENZIES JRW, MCKEE R,CORBETT AD: Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Regul Pept. (2001) 99:151–156.
  • LIU L, SHANG F, MARKUS I,BURCHER E: Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. I Pharmacol Exp. Ther. (2002) 302:627–635.
  • VREES MD, PRICOLO VE,POTENTI FM, CAO W:Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch. Surg. (2002) 137:439–445.
  • GRADY EF, YOSHIMI SK, MAA J et al: Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br. J. Pharmacol (2000) 130:505–512.
  • MAA J, GRADY EF, YOSHIMI SK et al.: Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice. Surgery (2000) 128:232–239.
  • BANG R, SASS G, KIEMER AK et al: Neurokinin-1 receptor antagonists CP96345 and L733060 protect mice from cytokine-mediated liver injury. ./. Pharinacol Exp. Ther. (2003) 305:31–39.
  • FOWLER CJ: Intravesical treatment of overactive bladder. Urology (2000) 55(Suppl. 5A):560–564.
  • DASGUPTA P, CHANDIRAMANI VA, BECKETT A, SCARAVILLI F,FOWLER CJ: The effect of intravesical capsaicin on suburothelial innervation in patients with detrusor hyperreflexia. Br. J. Urol. (2000) 85:238–245.
  • SHARKEY KA, WILLIAMS RG, SHULTZBERG M, DOCKRAY GJ: Sensory substance P innervation of the urinary bladder, possible site of action of capsaicin in causing urinary retention in rats. Neuroscience (1983) 10:861–868.
  • WAKABAYASHI Y, TOMOYOSHI T, FUJIMIYA M, ARAI R, MAEDA T: Substance P-containing axon terminals in the mucosa of the human urinary bladder: pre-embedding immunohistochemistry using cryostat sections for electron microscopy. Histocheinistry (1993) 100:401–407.
  • AVELINO A, CRUZ F:Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin and resiniferatoxin. Auton. Neurosci. (2000) 86:37–46.
  • MAGGI CA, SANTICIOLI P,GEPPETTI P et The contribution of capsaicin-sensitive innervation to activation of the spinal vesico-vesical reflex in rats: relationship between substance P levels in the urinary bladder and the sensory-efferent function of capsaicin-sensitive sensory neurons. Brain Res. (1987) 415:1–13.
  • CHENG CL, MA CP, DE GROAT WC: Effect of capsaicin on micturition and associated reflexes in chronic spinal rats. Brain Res. (1995) 678:40–48.
  • SHAKER HS, TV LM,KALFOPOULOS M, HASSOUNA M, DION S, ELHILALI M: Hyperreflexia of the urinary bladder: possible role of the efferent function of the capsaicin sensitive primary afferents. ./. Urol. (1998) 160:2232–2239.
  • ABDEL-GAWAD M, DION SB, ELHILALI MM: Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats. Urol. (2001) 165:1739–1744.
  • •Pathophysiological activation of the efferent function of capsaicin-sensitive primary afferent neurons.
  • ABDEL-KARIM A, BIALECKI R, ELHILALI MM: Effects of M274773, a new tachykinin NK2 receptor antagonist, on bladder function of spinalized rats. Br. J. Urol. Int. (2002) 90\(Suppl. 2):P-7.4.25.
  • LECCI A, MAGGI CA: Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept. (2001) 101:1–18.
  • CARSTAIRS JR, NIMMO AJ, MORRISON JFB: Autoradiographiccharacterization of prejunctional neurokinin receptors in the rat bladder. Neuropeptides (1992) 22:13–14.
  • MAGGI CA, GIULIANI S, SANTICIOLI P, ABELLI L, GIACHETTI A: Facilitation of reflex micturition by intravesical administration of [13A1a81-neurokinin A (4-10), a selective NK2 tachykinin receptor agonist. Um] (1991) 145:184–187.
  • ISHIZUKA 0, MATTIASSON A, ANDERSSON KE: Tachykinin effects on bladder activity in conscious normal rats. Um] (1995) 154:257–261.
  • ISHIZUKA 0, MATTIASSON A, ANDERSSON KE:Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? Um] (1995) 153:2034–2038.
  • LECCI A, TRAMONTANA M, GIULIANI S, CRISCUOLI M, MAGGI CA: Effect of tachykinin NK2 receptor blockade on detrusor hyperreflexia induced by bacterial toxin in rats.' Um] (1998) 160:206–209.
  • LECCI A, BIRDER LA, MEINI S et al: Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis. Br. Pharinacol (2000) 130:331–338.
  • ISHIZUKA 0, IGAWA Y,MATTIASSON A, ANDERSSON KE: Capsaicin-induced bladder hyperreactivity in normal conscious rats. j Um] (1994) 152:525–530.
  • LECCI A, GIULIANI S,TRAMONTANA M, CRISCUOLI M, MAGGI CA: MEN11420, a peptide tachykinin NK2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo. Naunyn Schiniedebergs Arch. Phannacol (1997) 356:182–188.
  • LECCI A, CARINI F, TRAMONTANA M et al.: Urodynamic effects induced by intravesical capsaicin in rats and hamsters. Auton. Neurosci. (2001) 91:37–46.
  • MAGGI CA, GIULIANI S, BALLATI L et al.: In vivo evidence for tachykininergic transmission using a new NK2 receptor selective antagonist. Pharinacol Exp. Ther. (1991b) 257:1172–1178.
  • PIETRA C, BETTELLINI R,HAGAN RM, WARD P, MCELROY A, TRIST DG: Effect of selective antagonists attachykinin NK1 and NK2 receptors on xylene-induced cystitis in rats. Neuropeptides (1992) 22:52.
  • PANDITA RK, ANDERSSON KE: Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats." Um] (2002) 168:1230–1234.
  • •Investigation into neurotransmitter systems involved in the effect of ATP on the bladder function.
  • BUSHFIELD M, METCALFE M, NAYLOR AM: Activation of micturition reflex by NK2 receptor stimulation in the anaesthetized guinea-pig. BE Pharinacol (1995) 115:875–882.
  • NIMMO AJ, ANDERSSON PO, MORRISON JFB: Reactive changes in neurokinin receptor density following selective denervations and outlet obstruction of rat bladder.j Physiol (1992) 446:524.
  • KIBBLE A, MORRISON JFB: Changes in mechanosensitivity and sensitization of urinary bladder afferents in the anesthetized rat following the administration of the selective NK2 antagonist SR48968. Physiol (1996) 497.P, 18P.
  • MORRISON JFB: The activation of bladder wall afferent nerves. Exp. Physiol (1999) 84:131–136.
  • IGGO A: Tension receptors in the stomach and the urinary bladder. I Physiol (1955) 128:593–607.
  • TRAMONTANA M, CATALIOTO RM, LECCI A, MAGGI CA: Role of prostanoids in the contraction induced by a tachykinin NK2 receptor agonist in the hamster urinary bladder. Naunyn Schrniedebergs Arch. Pharinacol (2000) 361:452–459.
  • MAGGI CA: Prostanoids as local modulators of reflex micturition. Pharinacol Res. (1992) 25:13–20.
  • FERGUSON DR, KENNEDY I, BURTON TJ: ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism?' Physiol (1997) 505(2):503–511.
  • •First hypothesis on the sensory role of ATP in the urinary bladder.
  • VLASKOVSKA M, KASALOV L,RONG W et al.: P2X3 knock-out mice reveal a major sensory role for urothelial releasedATP. J. Neurosci. (2001) 21:5670–5677.
  • •Evidence that ATP is physiologically Involved in afferent neuron excitation in the urinary bladder.
  • LAZZERI M, BENEFORTI P,SPINELLI M, ZANOLLO A., BARBAGLI G, TURINI D:Intravesical resiniferatoxin for the treatment of hypersensitive disorders: a randomized placebo-controlled study. Um] (2000) 164:676–679.
  • SILVA C, RIBEIRO MJ, CRUZ F: The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. " Um] (2002) 168:575–579.
  • RUGGIERI MR, FILER-MAERTEN S, HIEBLE JP, HAY DW: Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea-pig bladder. " Um] (2000) 164:197–202.
  • •Importance of TKs in a model of visceral pain as evaluated through pharmacological means.
  • KISS S, YOSHIYAMA M, CAO YC et al: Impaired response to chemical irritation of the urinary tract in mice with disruption of the preprotachykinin gene. Neurosci. Lett. (2001) 313:57–60.
  • •Importance of TKs in a model of visceral pain as evaluated through genetic manipulation.
  • RAO JN, DEBELJUK L, BARTKE A: Effects of tachykinins on the secretory activity of rat Sertoli cells in vitro. Endocrinology (1995) 136:1315–1318.
  • KUSHNER L, CHIU PY, BRETTSCHNEIDER N et al: Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology (2001) 57(Suppl. A):5129.
  • PANG X, MARCHAND J, SANT GR, KREAM RM, THEOHARIDES TC: Increased number of substance P positive nerve fibres in interstitial cystitis. Br. Um] (1995) 75:744–750.
  • SMET PJ, MOORE KH, JONAVICIUS J: Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab. Invest. (1997) 77:37–49.
  • PEEKER R, ALDENBERG F, DAHLSTROM A, JOHANSSON SL, LI JY, FALL M: Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic andnonulcer interstitial cystitis. J. Urol. (2000) 163:1112–1115.
  • CAMPBELL DJ, TENTS N,ROSAMILIA A, CLEMENTS JA, DWYER PL: Urinary levels of substance P and its metabolites are not increased in interstitial cystitis. Br. J. Urol. (2001) 87:35–38.
  • GIULIANI S, PATACCHINI R,BARBANTI G et al.: Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J. Pharmacol. Exp. Ther. (1993) 267:590–595.
  • ZENG XP, MOORE KH, BURCHER E: Characterization of tachykininNK2 receptors in human urinary bladder. Urol. (1995) 153:1688–1692.
  • SABAN R, SABAN MR, NGUYEN NB et al: Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am. Pathol. (2000) 156:775–780.
  • PALEA S, CORSI M, ARTIBANI W, OSTARDO E, PIETRA C: Pharmacological characterization of tachykinin NK2 receptors on isolated human urinary bladder, prostatic urethra and prostate../. Pharmacol. Exp. Ther. (1996) 277:700–705.
  • SABAN R, GERARD NP, SABAN MR, NGUYEN NB, DEBOER DJ, WERSHIL BK: Mast cells mediate substance P-induced bladder inflammation through an NK1 receptor-independent mechanism. Am. Physiol. Renal Physiol. (2002) 283:F616–F629.
  • •Elegant study highlighting complex relationships between mast cells and NK-1 receptors.
  • AHLUWALIA A, MAGGI CA, SANTICIOLI P, LECCI A, GIULIANI S: Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol. (1994) 111:1017–1022.
  • ALFIERI AB, GARDNER C:The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. Gen. Pharmacol. (1997) 29:245–250.
  • •First evidence indicating that a TK NK-1 receptor antagonist has a cytoprotective effect.
  • ALFIERI AB, CUBEDDU LX:Nitric oxide and NK1-tachykinin receptors in cyclophosphamide-induced cystitis, in rats. 1 Pharmacol. Exp. Ther. (2000) 295:824–829.
  • •Evidence that iNOS activity can be modulated through NK-1 receptor stimulation.
  • ALFIERI AB, MALAVE A,CUBEDDU LX: Nitric oxide synthases and cyclophosphamide-induced cystitis in rats. Naunyn Schmiedebergs Arch. Pharmacol. (2001) 363:353–357.
  • AHLUWALIA A, DE FELIPE C, O'BRIEN J, HUNT SP, PERRETTI M: Impaired IL-I3-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice. BE J. Pharmacol. (1998) 124:1013–1015.
  • ALFIERI AB, CUBEDDU LX:Role of NK1 receptors on cisplatin-induced nephrotoxicity in the rat.Naunyn Schmiedebergs Arch. Pharmacol. (2001) 361:334–338.
  • PAGE NM, WOODS RJ, GARDINER SM et al.: Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature (2000) 405:797–800.
  • •Endocrine role of NKB during pregnancy.
  • ROCCON A, MARCHIONNI D, NISATO D: Study of 5R142801, anew potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pigs. BE Pharmacol. (1996) 118:1095–1102.
  • GRANT AD, AKHTAR R, GERARD NP, BRAIN SD: Neurokinin B induces oedema formation in the mouse lung via tachykinin receptor-independent mechanisms. Physiol. (2002) 543:1007–1014.
  • •Suggestion for an effect of NKB not mediated by TK NK-1, -2, and -3 receptors.
  • LAU AH, CHOW SS, NG YS:Immunologically-induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P. Eur. Pharmacol. (2001) 414:295–303.
  • •Suggestion for an effect of SP (low doses) not mediated by TK NK-1, -2, and -3 receptors.
  • LAI JP, HO WZ, ZHAN GX, YI Y, COLLMAN RG, DOUGLAS SD: Substance P antagonist (CP-96,345) inhibits HIV replication in human mononuclear phagocytes. Proc. Natl. Acad. Sci. USA (2001) 98:3970–3975.
  • •A novel putative clinical application for TK NK-1 receptor antagonists.
  • LAI JP, HO WZ, YANG JH, WANG X,SONG L, DOUGLAS SD: A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes. J. Neuroimmunol. (2002) 128:101–108.
  • QIAN J, YEHIA G, MOLINA CA et al: Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5 --monophosphate response elements in its expression by IL-1 and stem cell factor. km-tuna (2001) 166:2553–2561.
  • SINGH D, JOSHI DD, HAMEED M et al.: Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc. Natl. Acad. Sci. USA (2001) 97:388–393.
  • GOTO T, TANAKA T: Tachykinins and tachykinin receptors in bone. Microscopy Res. Tech. (2002) 58:91–97.
  • KATAYAMA I, BAE SJ, HAMASAKI Y et al.: Stress response, tachykinin, and cutaneous inflammation. j Investig. Dermatol. Symp. Proc. (2001) 6:81–86.
  • SCHOLZEN T, ARMSTRONG CA, BUNNETT NW et al.: Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune system. Exp. Dermatol. (1998) 7:81–96.
  • TAI CF, BARANIUK JN: Upper airway neurogenic mechanisms. Curr. Opin. Allergy Immunol. (2002) 2:11–19.
  • BERTRAND C, GEPPETTI P:Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergy airway disease. Trends Pharmacol. Sci. (1996) 17:255–259.
  • COLLINS SM: The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology (1996) 111:1683–1699.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.